| Literature DB >> 21470582 |
L Bengrine-Lefevre1, P Afchain, B Chibaudel, H Gervais, C Tournigand, A De Gramont, C Louvet.
Abstract
A 52-year-old woman, with a metastatic breast cancer, presented with a nasal septum perforation while receiving a treatment combining paclitaxel and bevacizumab. This is the fifth reported case of nasal septum perforation probably related to an anti-angiogenic therapy. A literature review and a discussion concerning the different causes of nasal septum perforation were performed.Entities:
Mesh：
Substances：
Year: 2010 PMID： 21470582 DOI： 10.1016/j.revmed.2010.04.015
Source DB: PubMed Journal: Rev Med Interne ISSN： 0248-8663 Impact factor: 0.728